Form 8-K - Current report:
SEC Accession No. 0001193125-22-151768
Filing Date
2022-05-16
Accepted
2022-05-16 16:18:25
Documents
14
Period of Report
2022-05-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d355647d8k.htm   iXBRL 8-K 29808
2 EX-99.1 d355647dex991.htm EX-99.1 9977
6 GRAPHIC g355647g0514090930671.jpg GRAPHIC 3750
  Complete submission text file 0001193125-22-151768.txt   177189

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA aclx-20220513.xsd EX-101.SCH 2846
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE aclx-20220513_lab.xml EX-101.LAB 18739
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aclx-20220513_pre.xml EX-101.PRE 11701
8 EXTRACTED XBRL INSTANCE DOCUMENT d355647d8k_htm.xml XML 3467
Mailing Address 25 WEST WATKINS MILL ROAD SUITE A GAITHERSBURG MD 20878
Business Address 25 WEST WATKINS MILL ROAD SUITE A GAITHERSBURG MD 20878 240-723-6641
Arcellx, Inc. (Filer) CIK: 0001786205 (see all company filings)

EIN.: 472855917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41259 | Film No.: 22929363
SIC: 2836 Biological Products, (No Diagnostic Substances)